Nature Communications (Jun 2022)

Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine

  • Tal Patalon,
  • Yaki Saciuk,
  • Asaf Peretz,
  • Galit Perez,
  • Yoav Lurie,
  • Yasmin Maor,
  • Sivan Gazit

DOI
https://doi.org/10.1038/s41467-022-30884-6
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 7

Abstract

Read online

In this retrospective study, authors show that relative protection against SARS-CoV-2 infection wanes from 53.4% one month after vaccination to 16.5% three months after vaccination, suggesting that there is a significant waning of mRNA vaccine effectiveness against infection with the Omicron variant.